NCT03906461 - LSI (Lesion Index) Workflow Observational Study | Biotech Hunter

Enrollment

143

Participants

Timeline

Start Date

May 17, 2019

Primary Completion Date

April 27, 2021

Study Completion Date

April 27, 2021

Conditions

Paroxysmal Atrial Fibrillation

Interventions

DEVICE

Radiofrequency Ablation

The Tacticath Contact Force Ablation Catheter, Sensor Enabled (TactiCath SE) is designed to facilitate electrophysiological mapping of the heart chambers and to transmit radiofrequency (RF) current to the catheter tip electrode for intracardiac ablation purposes.

Trial Locations (9)

11219

Maimonides Medical Center, Brooklyn

32032

Ospedale Santa Maria del Prato, Feltre

38801

North Mississippi Medical Center, Tupelo

44137

St. Johannes Hospital, Dortmund

46260

St. Vincent Hospital, Indianapolis

94010

Mills-Peninsula Medical Center, Burlingame

113-8510

Tokyo Medical and Dental University Hospital of Medicine, Bunkyō-Ku

125-8506

The Jikei University Katsushika Medical Center, Katsushikachō

Unknown

Hospital Universitario de Monteprincipe, Boadilla del Monte